Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patients?

Felicetto Ferrara, Pellegrino Musto

Research output: Contribution to journalArticle

Abstract

The research with new agents is particularly active in acute myeloid leukemia (AML) and different studies suggest a potential utility of hypomethylating (HMA) agents in this disease. In this article, we critically appraise some recent clinical data reported on the use of HMA for the treatment of AML in older patient.

Original languageEnglish
Pages (from-to)3879-3881
Number of pages3
JournalCancer
Volume117
Issue number17
DOIs
Publication statusPublished - Sep 1 2011

Fingerprint

Acute Myeloid Leukemia
Therapeutics
Research

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly : For all, none, or which patients? / Ferrara, Felicetto; Musto, Pellegrino.

In: Cancer, Vol. 117, No. 17, 01.09.2011, p. 3879-3881.

Research output: Contribution to journalArticle

Ferrara, Felicetto ; Musto, Pellegrino. / Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly : For all, none, or which patients?. In: Cancer. 2011 ; Vol. 117, No. 17. pp. 3879-3881.
@article{6f87e282cf1f4947b0ca1c3d35fc0d5c,
title = "Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly: For all, none, or which patients?",
abstract = "The research with new agents is particularly active in acute myeloid leukemia (AML) and different studies suggest a potential utility of hypomethylating (HMA) agents in this disease. In this article, we critically appraise some recent clinical data reported on the use of HMA for the treatment of AML in older patient.",
author = "Felicetto Ferrara and Pellegrino Musto",
year = "2011",
month = "9",
day = "1",
doi = "10.1002/cncr.25934",
language = "English",
volume = "117",
pages = "3879--3881",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "17",

}

TY - JOUR

T1 - Hypomethylating agents for the treatment of acute myeloid leukemia in the elderly

T2 - For all, none, or which patients?

AU - Ferrara, Felicetto

AU - Musto, Pellegrino

PY - 2011/9/1

Y1 - 2011/9/1

N2 - The research with new agents is particularly active in acute myeloid leukemia (AML) and different studies suggest a potential utility of hypomethylating (HMA) agents in this disease. In this article, we critically appraise some recent clinical data reported on the use of HMA for the treatment of AML in older patient.

AB - The research with new agents is particularly active in acute myeloid leukemia (AML) and different studies suggest a potential utility of hypomethylating (HMA) agents in this disease. In this article, we critically appraise some recent clinical data reported on the use of HMA for the treatment of AML in older patient.

UR - http://www.scopus.com/inward/record.url?scp=80051941829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051941829&partnerID=8YFLogxK

U2 - 10.1002/cncr.25934

DO - 10.1002/cncr.25934

M3 - Article

C2 - 21287537

AN - SCOPUS:80051941829

VL - 117

SP - 3879

EP - 3881

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 17

ER -